● Overall, the company has poor fundamentals for a medium to long-term investment strategy.
● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
● Low profitability weakens the company.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● The overall consensus opinion of analysts has deteriorated sharply over the past four months.
● Over the past twelve months, analysts' consensus has been significantly revised downwards.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.